Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Pediatric Blood & Cancer|April 20, 2017
Improvement in treatment abandonment in pediatric patients with cancer in GuatemalaElysia Alvarez, Midori Seppa, Silvia Rivas, et al.Cancer Research|September 7, 2007
Requirement for Rac1 in a K-ras induced lung cancer in the mouseJoseph L Kissil, Marita J Walmsley, Linda Hanlon, et al.Nature Communications|July 5, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinomaKaja Kostyrko, Marta Román, Alex G Lee, et al.Nature Genetics|April 1, 2008
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonKevin M Haigis, Krystle R Kendall, Yufang Wang, et al.Cancer Discovery|July 31, 2020
Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and SusceptibilitiesMarcus R Kelly, Kaja Kostyrko, Kyuho Han, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma MetastasisMichael M Lizardo, Christopher Hughes, Yue Z Huang, et al.The Journal of Clinical Investigation|October 26, 2010
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human modelsSilvestre Vicent, Ron Chen, Leanne C Sayles, et al.Nature Biotechnology|September 15, 2020
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analysesJoshua Broyde, David R Simpson, Diana Murray, et al.Nature Genetics|May 9, 2024
Direct transposition of native DNA for sensitive multimodal single-molecule sequencingArjun S Nanda, Ke Wu, Iryna Irkliyenko, et al.Nature Communications|August 25, 2022
Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroidsHanbing Song, Simon Bucher, Katherine Rosenberg, et al.Pageof 9